Hematologic malignancies comprising leukemias, lymphomas and plasma cell disorders represent a diverse group of cancers originating in the blood, bone marrow, and lymphatic system. Over the last two decades, this field has witnessed remarkable progress, driven by advances in molecular diagnostics, targeted therapies, immunotherapy and supportive care. These innovations have transforme... https://avasahospital.com/haemato-oncology/